China Universal Asset Management Company’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.35M | Buy |
4,459
+30
| +0.7% | +$9.08K | 0.13% | 139 |
|
|
2025
Q1 | $1.47M | Sell |
4,429
-196
| -4% | -$64.9K | 0.14% | 139 |
|
|
2024
Q4 | $1.43M | Buy |
4,625
+449
| +11% | +$139K | 0.13% | 122 |
|
|
2024
Q3 | $886K | Buy |
4,176
+1,672
| +67% | +$355K | 0.1% | 149 |
|
|
2024
Q2 | $702K | Sell |
2,504
-1,297
| -34% | -$363K | 0.1% | 127 |
|
|
2024
Q1 | $1.02M | Buy |
3,801
+1,509
| +66% | +$403K | 0.13% | 129 |
|
|
2023
Q4 | $530K | Buy |
2,292
+1,824
| +390% | +$422K | 0.1% | 143 |
|
|
2023
Q3 | $68.3K | Buy |
468
+228
| +95% | +$33.3K | 0.02% | 219 |
|
|
2023
Q2 | $55.4K | Sell |
240
-6
| -2% | -$1.39K | 0.02% | 185 |
|
|
2023
Q1 | $59.6K | Buy |
246
+72
| +41% | +$17.4K | 0.02% | 147 |
|
|
2022
Q4 | $50.5K | Sell |
174
-2,424
| -93% | -$704K | 0.02% | 138 |
|
|
2022
Q3 | $169K | Buy |
+2,598
| New | +$169K | 0.07% | 97 |
|